,
, 23 III-1-a. Description de la sous-population (n = 68)
, Description de la population totale (n = 117)
Analyses univariée et multivariée de la sous-population (n = 68) ,
, Analyses univariée et multivariée de la population totale (n = 117)
, Analyse multivariée et création d'une valeur seuil
, 33 IV-1. Résumé des principaux résultats et confrontation avec la littérature
, IV-1-b. Variables de scanner
,
, The Biopsied Donor Liver: Incorporating Macrosteatosis into High-Risk Donor Assessment, vol.16, pp.874-84
Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease », Journal of Hepatology, vol.64, issue.6, pp.1388-1402, 2016. ,
Glycolysis and energy metabolism in rat liver during warm and cold ischemia: evidence of an activation of the regulatory enzyme phosphofructokinase, Cryobiology, vol.31, pp.441-452, 1994. ,
, Ischemic Injury in Liver Transplantation : Difference in Injury Sites between Warm and Cold Ischemia in Rats, vol.16, pp.454-61, 1992.
,
Stress in Hepatocytes and Stimulatory State of Kupffer Cells after Reperfusion Differ between Warm and Cold Ischemia in Rats, Liver, vol.14, issue.5, pp.234-274 ,
Beat Müllhaupt, et Pierre-Alain Clavien. « The Use of Fatty Liver Grafts in Modern Allocation Systems: Risk Assessment by the Balance of Risk (BAR) Score », Annals of Surgery, vol.256, issue.5, pp.861-69, 2012. ,
Model for End-Stage Liver Disease (MELD) and Allocation of Donor Livers, Gastroenterology, vol.124, issue.1, pp.91-96, 2003. ,
« Effects of Brain Death on Organ Quality and Transplant Outcome, Transplantation Reviews, vol.26, issue.2, pp.54-59, 2012. ,
« Effects of Brain Death and Hemodynamic Status on Function and Immunologic Activation of the Potential Donor Liver in the Rat, Annals of Surgery, vol.232, issue.6, pp.804-817, 2000. ,
« Manipulation of Lipid Metabolism During Normothermic Machine Perfusion: Effect of Defatting Therapies on Donor Liver Functional Recovery, Liver Transplantation, vol.25, issue.7, pp.1007-1029, 2019. ,
Sonal Nagpal, et al. « Metabolic and Lipidomic Profiling of Steatotic Human Livers during Ex Situ Normothermic Machine Perfusion Guides Resuscitation Strategies ». Édité par Pavel Strnad, PLOS ONE, vol.15, issue.1, p.228011 ,
Assessment of Hepatic Steatosis by Transplant Surgeon and Expert Pathologist: A Prospective, Double-Blind Evaluation of 201 Donor Livers: Assessment of Steatosis in Donor Livers, Liver Transplantation, vol.19, issue.4, pp.437-486, 2013. ,
« Comparison of CT Methods for Determining the Fat Content of the Liver », American Journal of Roentgenology, vol.188, issue.5, pp.1307-1319, 2007. ,
, Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods »: Medicine 95, p.2718, 2016.
« Predictive Value of Unenhanced Computerized Tomography for Detecting Hepatosteatosis in Living Liver Donors, Transplantation Proceedings, vol.47, issue.6, pp.1854-59, 2015. ,
« Noninvasive Assessment of Macrovesicular Liver Steatosis in Cadaveric Donors Based on Computed Tomography Liver-to-Spleen Attenuation Ratio: Assessment of Liver Steatosis, Liver Transplantation, vol.21, issue.5, pp.690-95, 2015. ,
,
« Unenhanced CT for Assessment of Macrovesicular Hepatic Steatosis in Living Liver Donors: Comparison of Visual Grading with Liver Attenuation Index, Radiology, vol.244, issue.2, pp.479-85, 2007. ,
,
,
Quantitative Measurement Techniques Using CT for Area of Fat and MR for Hepatic Steatosis, Clinical Nutrition, vol.37, issue.1, pp.214-236, 2018. ,
« Non-Invasive Assessment of Hepatic Steatosis: Prospective Comparison of the Accuracy of Imaging Examinations », Journal of Hepatology, vol.52, issue.4, pp.579-85, 2010. ,
« Assessment of Hepatic Steatosis in Patients Undergoing Liver Resection: Comparison of US, CT, T1-Weighted Dual-Echo MR Imaging, and Point-Resolved 1 H MR Spectroscopy, Radiology, vol.256, issue.1, pp.159-68, 2010. ,
Frédérique Capron, et Thierry Poynard. « Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease, Gastroenterology, vol.128, issue.7, pp.1898-1906, 2005. ,
, The New Reference Standard in Quantifying Hepatic Steatosis? » Gut 61, pp.117-144, 2012.
« Prediction of Nonalcoholic Fatty Liver in Prospective Liver Donors, Clinical Transplantation, vol.31, issue.4, p.12890, 2017. ,
« A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research, Journal of Chiropractic Medicine, vol.15, issue.2, pp.155-63, 2016. ,
« Transient Elastography (FibroScan ® ) with Controlled Attenuation Parameter in the Assessment of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease -Where Do We Stand?, World Journal of Gastroenterology, vol.22, p.7236, 2016. ,
« Utility of Transient Elastography (Fibroscan) and Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease (NAFLD) in Morbidly Obese Patients ». Surgery for Obesity and Related Diseases 14, pp.81-91, 2018. ,
« Evaluating Feasibility and Accuracy of Non-Invasive Tests for Nonalcoholic Fatty Liver Disease in Severe and Morbid Obesity », International Journal of Obesity, vol.42, issue.11, pp.1900-1911, 2018. ,
,
, « Macrovesicular Steatosis in Living Related Liver Donors: Correlation of Biopsy Findings with CT Liver Attenuation Index and Body Mass Index, vol.30, pp.1016-1036, 2016.
« Association of Nonalcoholic Fatty Liver Disease With Visceral Adiposity but Not Coronary Artery Calcification in the Elderly », Clinical Gastroenterology and Hepatology, vol.14, issue.9, pp.1337-1344, 2016. ,
« The Association between Liver Fat and Systemic Calcified Atherosclerosis », Journal of Vascular Surgery, vol.71, issue.1, pp.204-211, 2020. ,
« Radiologic Evaluation of Nonalcoholic Fatty Liver Disease, World Journal of Gastroenterology, vol.20, p.7392, 2014. ,
« Intimate Association of Visceral Obesity with Non-Alcoholic Fatty Liver Disease in Healthy Asians: A Case-Control Study: Hepatic Steatosis and Visceral Obesity, Journal of Gastroenterology and Hepatology, vol.30, issue.11, pp.1666-72, 2015. ,
« Frozen Section Diagnosis in Donor Liver Biopsies: Observer Variation of Semiquantitative and Quantitative Steatosis Assessment, Virchows Archiv, vol.461, issue.2, pp.177-83, 2012. ,
,
, Au moment d'être admis(e) à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité
, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux, individuels et sociaux
, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte
, Admis(e) dans l'intimité des personnes, je tairai les secrets qui me seront confiés
, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité
, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses
, que je sois déshonoré(e) et méprisé(e) si j'y manque